Study evaluated the changes in the transmission of EV-D68 in England inferred from seroprevalence data.
AstraZeneca scores its second paediatric approval for Soliris in Japan – Pharmaceutical Technology
Soliris has previously been approved for use in paediatric and adult populations with paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) in the